Corsair Capital Management’s TransCode Therapeutics RNAZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,429	Closed	-$19.8K	–	166
2025 Q1	$19.8K	Buy	+1,429	New	+$19.8K	0.01%	118